Skip to content
★ Sign in to follow
BC

BlueLine Catalyst Fund IX, L.P.

Executive
Related company / holding
Integramed America IncIridex CorpDaegis Inc.
Total declarations
82
Companies
3
▲ Purchases (82 ops.)
€2.3M
▼ Sales (0 ops.)
—

Latest filing published 12 Nov 2014 for IRIDEX CORP, €81k.

Insider track record

Disclosed buys
82
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
82
Positive at T+90
85%
Median T+90
+20.2%

Based on 20 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 12 Nov 2014 · 4379 days ago · €81k
    +19.7%
    Entry US$8.18 · Close at T+365 US$9.79
  • Filed 07 Nov 2014 · 4384 days ago · €17k
    +14.2%
    Entry US$8.12 · Close at T+365 US$9.27
  • Filed 05 Sept 2014 · 4447 days ago · €49k
    -14.5%
    Entry US$8.02 · Close at T+365 US$6.86
  • Filed 29 Aug 2014 · 4454 days ago · €2,865
    -4.0%
    Entry US$7.00 · Close at T+365 US$6.72
  • Filed 09 Jun 2014 · 4535 days ago · €45k
    +7.2%
    Entry US$8.23 · Close at T+365 US$8.82

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

BlueLine Catalyst Fund IX, L.P.: trading record in brief

BlueLine Catalyst Fund IX, L.P. is a declared insider at 3 companies; the most frequent names are Daegis Inc., Iridex Corp and Integramed America Inc. Over a trading history stretching from 29 July 2010 to 12 October 2014, the count stands at 82 filings.

Purchases make up the whole of the open-market record (82 purchases, €2.3M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2014: 17 purchases and no sales on the market.

In size, the median ticket on the buying side is €14k. After 20 purchases with a full 90-day history, the hit rate stands at 85% and the median 90-day move at +20.2%. These figures describe past trades and do not predict future prices.

The newest entry dates from 12 November 2014: an open-market purchase of €81k, in Iridex Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to BlueLine Catalyst Fund IX, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations71 total

25 of 71 declarations